X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Solara Active Pharma Sciences Ltd.
BSE CODE: 541540   |   NSE CODE: SOLARA   |   ISIN CODE : INE624Z01016   |   13-Feb-2026 Hrs IST
BSE NSE
Rs. 499.60
19.5 ( 4.06% )
 
Prev Close ( Rs.)
480.10
Open ( Rs.)
478.40
 
High ( Rs.)
503.90
Low ( Rs.)
471.80
 
Volume
12155
Week Avg.Volume
12453
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 499.60
19.55 ( 4.07% )
 
Prev Close ( Rs.)
480.05
Open ( Rs.)
480.05
 
High ( Rs.)
504.45
Low ( Rs.)
469.95
 
Volume
98574
Week Avg.Volume
229552
 
52 WK High-Low Range(Rs.)
440.2
734.4
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-0.27  -157.46  -6.17  -16.27  61.50  
   CEPS(Rs)24.39  -118.75  22.71  13.68  84.46  
   DPS(Rs)0.00  0.00  0.00  0.00  7.00  
   Book NAV/Share(Rs)271.53  259.94  417.24  423.90  442.25  
   Tax Rate(%)0.00  -16.08  50.40  36.11  0.00  
Margin Ratios          
   Core EBITDA Margin(%)15.88  -7.38  9.28  6.34  23.83  
   EBIT Margin(%)8.86  -29.67  3.14  -1.29  18.89  
   Pre Tax Margin(%)-0.08  -37.89  -3.10  -7.23  13.67  
   PAT Margin (%)-0.08  -43.98  -1.54  -4.62  13.67  
   Cash Profit Margin (%)7.65  -35.99  6.14  4.21  20.36  
Performance Ratios          
   ROA(%)-0.05  -21.96  -0.78  -2.14  9.33  
   ROE(%)-0.11  -46.51  -1.47  -3.76  17.13  
   ROCE(%)5.97  -17.22  1.79  -0.69  15.28  
   Asset Turnover(x)0.56  0.50  0.51  0.46  0.68  
   Sales/Fixed Asset(x)0.68  0.69  0.80  0.74  0.99  
   Working Capital/Sales(x)-6.13  -2.88  15.24  6.90  5.93  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.46  1.45  1.25  1.35  1.01  
   Receivable days96.35  126.14  130.11  140.07  80.53  
   Inventory Days96.33  129.95  143.29  125.26  64.87  
   Payable days160.32  137.92  131.69  160.25  131.34  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  22.67  
   PCE(x)21.02  -2.89  13.33  44.80  15.21  
   Price/Book(x)1.89  1.43  0.79  1.57  3.15  
   Yield(%)0.00  0.00  0.00  0.00  0.50  
   EV/Net Sales(x)2.21  1.81  1.51  2.66  3.35  
   EV/Core EBITDA(x)13.31  -26.00  13.92  34.02  13.10  
   EV/EBIT(x)24.93  -6.10  48.03  -205.73  17.74  
   EV/CE(x)1.51  1.20  0.87  1.32  2.46  
   M Cap / Sales1.61  1.04  0.82  1.89  3.10  
Growth Ratio          
   Net Sales Growth(%)-0.40  -10.73  13.83  -21.56  22.33  
   Core EBITDA Growth(%)337.46  -157.43  57.58  -76.05  45.66  
   EBIT Growth(%)129.74  -944.43  376.27  -105.37  60.44  
   PAT Growth(%)99.81  -2452.32  62.07  -126.50  96.43  
   EPS Growth(%)99.83  -2452.32  62.07  -126.45  46.79  
Financial Stability Ratios          
   Total Debt/Equity(x)0.71  1.07  0.67  0.67  0.38  
   Current Ratio(x)0.78  0.64  1.09  1.17  1.35  
   Quick Ratio(x)0.44  0.35  0.58  0.63  0.97  
   Interest Cover(x)0.99  -3.61  0.50  -0.22  3.62  
   Total Debt/Mcap(x)0.32  0.75  0.85  0.43  0.12